Representative End User Clients
Representative Automation Clients
Representative Software Clients
Global pharmaceutical company Novartis has grown over the years due to acquisitions. Today, the company aims to increase transparency and simplify its governance structures and employee empowerment. To this end, Novartis recently implemented a common shared services organization. As we learned during Antonio Buendia's presentation at the OSIsoft EMEA Users Conference in Lisbon, Sept 22, 2014, this philosophy also impacts manufacturing.
Mr. Buendia is the head of manufacturing process controls, automation and electrical of Novartis Pharma, the innovation-driven pharmaceutical business of Novartis. His visionary plenary presentation explained the division's automation strategy for manufacturing and the progress achieved so far.
The strategy includes rigorous standardization and paperless workflow, supporting the operational goals. Mr. Buendia explained the three main steps in the execution of his strategy: providing the right data to the right people at the right moment; providing manufacturing control using these data; and enabling the user to analyze, take corrective action, improve, and take preventive action. Novartis' "Workcenter of the Future" environment enables this strategy.
Novartis applies a similar approach to engineering software, using a rigorous integrated, paperless engineering and qualification process. ARC recently published a white paper that discussed this approach and Novar-tis' CEO Mr. Jimenez's role in promoting innovative modular process de-sign.
ARC Advisory Group clients can view the complete report at this Link.
If you would like to buy this report or obtain information about how to become a client, please Request ARC Info
Keywords: Novartis, OSIsoft, Automation Strategy, Standardization, Simplifica-tion, Machine Interfacing, Application Interfacing, Data Gateway, ARC Advisory Group.